Evaluation of three novel antigens and costimulatory agents for improvement of M. Tuberculosis specific interferon gamma release assays
Abstract Background Mycobacterium tuberculosis (MT) infections represent a global health problem and latent tuberculosis infection (LTBI) affects an estimated 25% of the world population. 10.6 million people fell ill with tuberculosis (TB) worldwide in 2021 and a total of 1.6 million TB-associated d...
Saved in:
Main Authors: | Sandra Schwarzlose-Schwarck, Mark Reinwald, Torsten Bauer, Florian Hentschel, Til Kiderlen, Dorinja Zapf, Victor Herbst, Stefan Lüth, David Krieger, Werner Dammermann |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12879-025-10577-3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predictors of interferon-gamma release assay results and their association with COVID-19 infection outcomes
by: S.J.W. Kang, et al.
Published: (2024-10-01) -
HIV and diabetes impair M. tuberculosis-specific interferon-gamma responses on QuantiFERON-TB Gold Plus testing
by: J.S. Zifodya, et al.
Published: (2024-05-01) -
Editorial: Immunology of food-borne parasites: recent progress and future advances
by: Saeed El-Ashram, et al.
Published: (2025-01-01) -
Candidate approaches for predicting vitiligo recurrence: an effective model and biomarkers
by: Binhao Liu, et al.
Published: (2025-02-01) -
Pentoxifylline Prevents Autoimmune MediatedInflammation in Low Dose Streptozotocin InducedDiabetes
by: Stanislava D. Stošić-Grujičić, et al.
Published: (2001-01-01)